Home Tags Drug pricing

Tag: Drug pricing

Nat Turner, 32, is the cofounder and CEO of Flatiron Health.

Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinica...

Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
Laura Marston holds up a vial of Humalog, a type of insulin she takes for type 1 diabetes at her home in Washington, DC September 27, 2016. When she was first diagnosed at 14, the list price for the drug was $21 per vial.

A drugmaker just slashed the price of its life-saving medication by 50%, but people are worried the $137 price tag is still unaffordable

The lower insulin price might still be unaffordable for many people with diabetes, especially those who pay the full price for the drug.
A Type 1 diabetes patient holds up bottles of insulin including Humalog. Lilly is now offering its insulin as an authorized generic at half the list price of the branded version.

A drugmaker just released a half-price version of a life-saving diabetes medication in a bet that a lower price tag will help it escape the political ...

Eli Lilly plans to make a generic version of its life-saving diabetes medication Humalog and sell it for half the price of the branded drug.

Dispensed: Pharma CEOs on Capitol Hill, the exploding CBD market, and treating kids with new models of primary care

Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.

Pharma companies want the government to do something about high drug prices, so long as it’s not forcing them to lower their drug prices

Pharmaceutical executives seemed to reach a consensus that it'll take government action to solve the conundrum of how we get to lower drug prices.
Sanofi released this chart breaking down the French drugmaker's US sales last year as part of a congressional drug price hearing on Tuesday.

The CEO of a $210 billion pharma company says that US drug prices are working against patients. One chart explains why.

The CEO of the French drugmaker Sanofi provided an unusual look behind the curtain of US drug prices.

Congress will grill 7 top pharma executives over the high cost of drugs today. Here’s how they’re set to shift the blame.

Pharma CEOs are likely to blame drug rebates for the high cost of their treatments, echoing an argument the industry has been using frequently.

The Trump administration just took its biggest step yet to bring down the cost of prescription drugs — and it’s dividing the healthcare in...

The aim is for patients to pay less for their drugs at the pharmacy counter, a major goal of the Trump administration.

Trump’s new plan to drive down drug prices to fight ‘global freeloaders’ sounds exactly like what those ‘freeloaders’ ar...

President Donald Trump has decried "global freeloading" as driving up US drug prices, but his new plan looks similar to what other countries do.
Chairman and CEO of Merck & Co., Kenneth Frazier, takes part in a panel discussion during the Clinton Global Initiative's annual meeting in New York, September 27, 2015.

The CEO of Merck has an ominous warning for the middlemen who stand between drug makers and patients

Merck CEO Kenneth Frazier thinks something has to change within the pharmaceutical industry to fix the issue of drug pricing. "I don't understand where we live in a world where 50% of the value goes to supply chain," Frazier said at an event at the Economic Club of New York.